US Patent Issued to CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) on June 2 for "Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone" (Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,778, issued on June 2, was assigned to CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd (Shijiazhuang, China).

"Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone" was invented by Chunlei Li (Shijiazhuang, China), Xuefang Xia (Shijiazhuang, China), Yanhui Li (Shijiazhuang, China), Na An (Shijiazhuang, China), Yanling Du (Shijiazhuang, China), Tong Li (Shijiazhuang, China), Shixia Wang (Shijiazhuang, China) and Runlu Jia (Shijiazhuang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The use of a mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone in the prepara...